Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BMS-663068 on Rosuvastatin PK
NCT02234882Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Sep 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of fostemsavir in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Primary endpoints: Maximum observed plasma concentration of rosuvastatin and Area under the concentration-time curve from time zero extrapolated to infinite time of rosuvastatin. Started Sep 2014; status: completed.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02234882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02234882.